A modest increase in heart rate was also observed, a signal seen with other incretin-based weight-loss agents
The rise of GLP-1 medications could potentially represent more than just another market headwind, fundamentally reshaping consumer behavior and, by extension, the CPG landscape
Glutathione S-transferases YcYfetus and YcYckinetic and inhibitor studies relating to their glutathione peroxidase activities
Patients should be advised to report any worsening of digestive symptoms promptly, and dose titration may need to be slower than standard protocols to optimise tolerance
Data will be made available after research completion, and approval of the product and product use in the European Union and the USA
Don't have gut issues, I don't take glutamine for that reason